ERBB2 and breast carcinoma: This report is limited by its single-patient nature and the absence of comprehensive genomic profiling; however, it provides useful real-world insight into the individualized use of T-DXd in an elderly, frail patient with HR+/HER2-low breast cancer complicated by pleural effusion.